Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications.

Musella M, Manic G, De Maria R, Vitale I, Sistigu A.

Oncoimmunology. 2017 Apr 5;6(5):e1314424. doi: 10.1080/2162402X.2017.1314424. eCollection 2017. Review.

2.

Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus Erythematosus.

Stypińska B, Paradowska-Gorycka A.

Int J Mol Sci. 2015 Oct 13;16(10):24194-218. doi: 10.3390/ijms161024194. Review.

3.

Combining immunotherapy with oncogene-targeted therapy: a new road for melanoma treatment.

Aris M, Barrio MM.

Front Immunol. 2015 Feb 9;6:46. doi: 10.3389/fimmu.2015.00046. eCollection 2015. Review.

4.

Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia.

Zhang W, Trachootham D, Liu J, Chen G, Pelicano H, Garcia-Prieto C, Lu W, Burger JA, Croce CM, Plunkett W, Keating MJ, Huang P.

Nat Cell Biol. 2012 Feb 19;14(3):276-86. doi: 10.1038/ncb2432.

5.

Cancer-stromal interactions: role in cell survival, metabolism and drug sensitivity.

Zhang W, Huang P.

Cancer Biol Ther. 2011 Jan 15;11(2):150-6. Epub 2011 Jan 15. Review.

6.

Antiproliferative Properties of Type I and Type II Interferon.

Bekisz J, Baron S, Balinsky C, Morrow A, Zoon KC.

Pharmaceuticals (Basel). 2010 Mar 30;3(4):994-1015.

7.

Karyotypic and molecular abnormalities in chronic lymphocytic leukaemia.

Fegan CD, Davies FE.

Clin Mol Pathol. 1996 Aug;49(4):M185-91. No abstract available.

8.

Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma.

Tracey L, Villuendas R, Ortiz P, Dopazo A, Spiteri I, Lombardia L, Rodríguez-Peralto JL, Fernández-Herrera J, Hernández A, Fraga J, Dominguez O, Herrero J, Alonso MA, Dopazo J, Piris MA.

Am J Pathol. 2002 Nov;161(5):1825-37.

9.

Regulation of apoptosis in myeloid cells by interferon consensus sequence-binding protein.

Gabriele L, Phung J, Fukumoto J, Segal D, Wang IM, Giannakakou P, Giese NA, Ozato K, Morse HC 3rd.

J Exp Med. 1999 Aug 2;190(3):411-21. Erratum in: J Exp Med 1999 Dec 6;190(11):following 1722.

Supplemental Content

Support Center